Digital Musculoskeletal Investment Trends 2024 and Future Innovation in the Digital MSK market
Lloyd Price
APRIL 30, 2024
Digital Therapeutics (DTx) for MSK Conditions: FDA-approved DTx programs can offer targeted interventions for specific MSK conditions, using biofeedback, educational modules, and personalized coaching to manage pain and improve function. billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 27.4%
Let's personalize your content